• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK UNKNOWN (SURPASS STREAMLINE); INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK UNKNOWN (SURPASS STREAMLINE); INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Catalog Number UNK_NEU
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Stenosis (2263)
Event Date 12/10/2019
Event Type  Injury  
Manufacturer Narrative
The neurovascular stryker surpass evolve device is not currently approved or commercially sold in the usa.The event for the surpass evolve device was filed to fda as a similar product to stryker device surpass streamline device that is commercially available in the us (pma # p170024).See section 4.11.3 guidance for industry and food and drug administration staff, november 8, 2016.The device remains implanted in the patient.
 
Event Description
It was reported that a patient had their para ophthalmic aneurysm treated with the stent flow diverter (subject device) on (b)(6) 2019 and approximately two weeks later, the patient was presented with a minor narrowing(40 -50%) of their supraclinoid ica just distal to the distal edge of the stent flow diverter.The cause of the narrowing of the vessel was not confirmed and may or may not be attributed to the implant.A secondary procedure was performed to extend the stent distally with another stent (non-stryker stent) and post angioplasty.The angiographic result showed that the narrowing had been fixed, and the patient has recovered well.The patient was reported to be in good condition.No further information is available.
 
Manufacturer Narrative
B5: updated to reflect received from hospital on (b)(6) 2020.Although the dhr could not be reviewed because the lot number remains unknown, there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device was not returned for analysis and remains implanted in the patient; therefore, physical as well as a functional testing could not be performed.The reported issue is covered in the device directions for use.The risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.As per the product dfu, experience with endovascular implants indicates that there is a risk of stenosis.Subsequent stenosis may require dilatation of the vessel segment containing the device.Based on additional information received, the reported event has been assessed as parent vessel stenosis instead of re-stenosis of the treated vessel.However, vessel dissection is a known risk associated with endovascular procedures and is noted as such in the device directions for use (dfu); therefore, an assignable cause of anticipated procedural complication was assigned to this event.
 
Event Description
It was reported that a patient had their para ophthalmic aneurysm treated with the stent flow diverter (subject device) on 26-nov-2019 and approximately two weeks later, the patient was presented with a minor narrowing(40 -50%) of their supraclinoid ica just distal to the distal edge of the stent flow diverter.The cause of the narrowing of the vessel was not confirmed and may or may not be attributed to the implant.A secondary procedure was performed to extend the stent distally with another stent (non-stryker stent) and post angioplasty.The angiographic result showed that the narrowing had been fixed, and the patient has recovered well.The patient was reported to be in good condition.No further information is available.It was additionally confirmed on 25-feb-2020 with the hospital that the reported 40-50% narrowing (parent vessel stenosis) reported occurred two weeks post-procedure.There was no device malfunction during the procedure as well.No further information available at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN (SURPASS STREAMLINE)
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
IE  NA
MDR Report Key9533596
MDR Text Key176098997
Report Number3008881809-2019-00415
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
PMA/PMN Number
P170024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 03/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/30/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Catalogue NumberUNK_NEU
Device Lot Number21570416
Was Device Available for Evaluation? No
Date Manufacturer Received02/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-